<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T0006" orientation="portrait" position="float">
 <object-id pub-id-type="doi">10.1080/21505594.2019.1605803-T0006</object-id>
 <label>Table 6.</label>
 <caption>
  <p>Summary of influenza virus infection and UPR pathway.</p>
 </caption>
 <!--OASIS TABLE HERE-->
 <table frame="hsides" rules="groups">
  <colgroup>
   <col width="1*" align="left"/>
   <col width="1*" align="left"/>
   <col width="1*" align="left"/>
  </colgroup>
  <thead>
   <tr>
    <th align="left">Reference</th>
    <th align="center">Summary of the study</th>
    <th align="center">Conclusions</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left">
     <xref rid="CIT0318">
      <sup>[318]</sup>
     </xref>
    </td>
    <td align="left">Studied ER stress and UPR in IAV infection in the lung epithelial cells</td>
    <td align="left">IAV infection activates IRE1 pathway with subsequent XBP-1 splicing</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="CIT0319">
      <sup>[319]</sup>
     </xref>
    </td>
    <td align="left">MxA antiviral activity against IAV</td>
    <td align="left">Involved in BiP mRNA expression and XBP-1 mRNA processing</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="CIT0320">
      <sup>[320]</sup>
     </xref>
    </td>
    <td align="left">Studied UPR in murine primary tracheal epithelial cells</td>
    <td align="left">IAV infection induced ER-stress via ATF6 and ERp57, but not CHOP, through caspase-12</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="CIT0321">
      <sup>[321]</sup>
     </xref>
    </td>
    <td align="left">P58
     <sup>IPK</sup> role in IAV infection
    </td>
    <td align="left">-May act synergistically with the UPR-mediated transcriptional activation to help IV relief from both PKR- and PERK-mediated translational repression</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="CIT0322">
      <sup>[322]</sup>
     </xref>
    </td>
    <td align="left"> </td>
    <td align="left">-Regulates eIF2a, and then regulates IV infection independent of PERK</td>
   </tr>
   <tr>
    <td align="left">
     <xref rid="CIT0323">
      <sup>[323]</sup>
     </xref>
    </td>
    <td align="left">Studied HA glycoprotein degradation</td>
    <td align="left">Innate immune induction by HA through ERAD by the critical role of class I α-mannosidases (EDEM1, EDEM2, and ERManI) in initiating HA degradation</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
